(Q50044857)

24 February 2018

title

Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study. (English)

1 reference

24 February 2018

main subject

Serenoa repens

object named as

Serenoa repens

1 reference

3

1 reference

24 February 2018

author name string

Giulio Bonvissuto

1

1 reference

24 February 2018

Letteria Minutoli

2

1 reference

24 February 2018

Alessandra Bitto

4

1 reference

24 February 2018

Francesca Polito

5

1 reference

24 February 2018

Natasha Irrera

6

1 reference

24 February 2018

Herbert Marini

7

1 reference

24 February 2018

Francesco Squadrito

8

1 reference

24 February 2018

Domenica Altavilla

9

1 reference

24 February 2018

language of work or name

English

0 references

publication date

15 December 2010

1 reference

24 February 2018

published in

Urology

1 reference

24 February 2018

volume

77

1 reference

24 February 2018

issue

1

1 reference

24 February 2018

page(s)

248.e9-16

1 reference

24 February 2018

Benign prostatic hyperplasia: age-related tissue-remodeling

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

The natural history of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Molecular and cellular pathogenesis of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Inflammation and chronic prostatic diseases: evidence for a link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Strategies to preserve prostate health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Preventing diseases of the prostate in the elderly using hormones and nutriceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Pharmacological effects of saw palmetto extract in the lower urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Lycopene inhibits disease progression in patients with benign prostate hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Lycopene: modes of action to promote prostate health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Lycopene inhibits the growth of normal human prostate epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Trehalose: a biophysics approach to modulate the inflammatory response during endotoxic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Animal models in urological disease and sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Growth factors in benign prostatic hyperplasia: basic science implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

The role of combination medical therapy in benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Saw palmetto for benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Tomatoes and lycopene in prevention and therapy--is there an evidence for prostate diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.07.514

10.1016/J.UROLOGY.2010.07.514

7 January 2021

Identifiers

DOI

1 reference

24 February 2018

PubMed ID

21109292

1 reference

24 February 2018